Cervical cancer and potential pharmacological treatment with snake venoms

Alejandro Montoya-Gómez1, Leonel Montealegre-Sánchez2, Herney Andrés García-Perdomo3

  • 1Grupo de Nutrición, Facultad de Salud, Universidad del Valle, Calle 4B # 36-00, Edificio 116, Oficina 5002, Cali, Colombia. gabriel.montoya@correounivalle.edu.co.

Insights

Snake venom toxins show promise for new cervical cancer treatments. Research explores these toxins

Area of Science:

  • Oncology
  • Pharmacology
  • Toxicology

Background:

  • Cervical cancer is a significant global health issue for women.
  • Reactivating apoptosis is a key strategy to reduce cancer cell proliferation.
  • Current treatments require enhancement for efficacy and reduced toxicity.

Purpose of the Study:

  • To review cervical cancer characteristics, risk factors, and treatments.
  • To investigate the potential of snake venom toxins as novel therapeutic agents.
  • To evaluate the effects of Viperidae family toxins on cervical cancer cell lines.

Main Methods:

  • Literature review of cervical cancer epidemiology and therapeutic strategies.
  • Identification and isolation of toxins from Viperidae snake venoms.
  • In vitro testing of isolated toxins on cervical cancer cell lines.

Main Results:

  • Viperidae snake venom toxins demonstrated effects on cervical cancer cell lines.
  • Potential for inducing apoptosis and inhibiting cell migration and angiogenesis was observed.
  • These toxins may offer a novel approach to targeting the tumor microenvironment.

Conclusions:

  • Snake venom toxins represent a promising source for developing new cervical cancer drugs.
  • Further research is warranted to explore their therapeutic potential and minimize side effects.
  • Targeting apoptosis and the tumor microenvironment is crucial for effective treatment.

Related Concept Videos

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists01:28

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy.  SP binds and activates...
445
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids01:21

Chemotherapy-Induced Nausea and Vomiting: Cannabinoids

Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
595
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists01:27

Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists

5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
515
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
869
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists01:29

Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists

Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
721
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.5K